N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα)

Dima A. Sabbah; Neka A. Simms; Wang Wang; Yuxiang Dong; Edward L. Ezell; Michael G. Brattain; Jonathan L. Vennerstrom; Haizhen A. Zhong

doi:10.1016/j.bmc.2012.09.059

N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα)

Dima A. Sabbah, Neka A. Simms, Wang Wang, Yuxiang Dong, Edward L. Ezell, Michael G. Brattain, Jonathan L. Vennerstrom, Haizhen A. Zhong

Research output: Contribution to journal › Article

24 Scopus citations

Abstract

This work describes our efforts to optimize the lead PI3Kα inhibitor N-benzyl 4-hydroxy-2-quinolone-3-carboxamide using structure-based design and molecular docking. We identified a series of N-phenyl 4-hydroxy-2-quinolone-3- carboxamides as selective inhibitors of mutant H1047R versus wild-type PI3Kα and we also showed that the cell growth inhibition by these compounds likely occurs by inhibiting the formation of pAKT and induction of apoptosis.

Original language	English (US)
Pages (from-to)	7175-7183
Number of pages	9
Journal	Bioorganic and Medicinal Chemistry
Volume	20
Issue number	24
DOIs	https://doi.org/10.1016/j.bmc.2012.09.059
State	Published - Dec 15 2012

Keywords

AKT phosphorylation
Apoptosis
Colon cancer
PI3K
Selectivity

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/j.bmc.2012.09.059

Fingerprint Dive into the research topics of 'N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα)'. Together they form a unique fingerprint.

Cite this

Sabbah, D. A., Simms, N. A., Wang, W., Dong, Y., Ezell, E. L., Brattain, M. G., Vennerstrom, J. L., & Zhong, H. A. (2012). N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα). Bioorganic and Medicinal Chemistry, 20(24), 7175-7183. https://doi.org/10.1016/j.bmc.2012.09.059

N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα). / Sabbah, Dima A.; Simms, Neka A.; Wang, Wang; Dong, Yuxiang; Ezell, Edward L.; Brattain, Michael G.; Vennerstrom, Jonathan L.; Zhong, Haizhen A.

In: Bioorganic and Medicinal Chemistry, Vol. 20, No. 24, 15.12.2012, p. 7175-7183.

Research output: Contribution to journal › Article

@article{a123af608569428ab3efae14c1c5ea80,

title = "N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα)",

abstract = "This work describes our efforts to optimize the lead PI3Kα inhibitor N-benzyl 4-hydroxy-2-quinolone-3-carboxamide using structure-based design and molecular docking. We identified a series of N-phenyl 4-hydroxy-2-quinolone-3- carboxamides as selective inhibitors of mutant H1047R versus wild-type PI3Kα and we also showed that the cell growth inhibition by these compounds likely occurs by inhibiting the formation of pAKT and induction of apoptosis.",

keywords = "AKT phosphorylation, Apoptosis, Colon cancer, PI3K, Selectivity",

author = "Sabbah, {Dima A.} and Simms, {Neka A.} and Wang Wang and Yuxiang Dong and Ezell, {Edward L.} and Brattain, {Michael G.} and Vennerstrom, {Jonathan L.} and Zhong, {Haizhen A.}",

year = "2012",

month = dec,

day = "15",

doi = "10.1016/j.bmc.2012.09.059",

language = "English (US)",

volume = "20",

pages = "7175--7183",

journal = "Bioorganic and Medicinal Chemistry",

issn = "0968-0896",

publisher = "Elsevier Limited",

number = "24",

}

TY - JOUR

T1 - N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα)

AU - Sabbah, Dima A.

AU - Simms, Neka A.

AU - Wang, Wang

AU - Dong, Yuxiang

AU - Ezell, Edward L.

AU - Brattain, Michael G.

AU - Vennerstrom, Jonathan L.

AU - Zhong, Haizhen A.

PY - 2012/12/15

Y1 - 2012/12/15

N2 - This work describes our efforts to optimize the lead PI3Kα inhibitor N-benzyl 4-hydroxy-2-quinolone-3-carboxamide using structure-based design and molecular docking. We identified a series of N-phenyl 4-hydroxy-2-quinolone-3- carboxamides as selective inhibitors of mutant H1047R versus wild-type PI3Kα and we also showed that the cell growth inhibition by these compounds likely occurs by inhibiting the formation of pAKT and induction of apoptosis.

AB - This work describes our efforts to optimize the lead PI3Kα inhibitor N-benzyl 4-hydroxy-2-quinolone-3-carboxamide using structure-based design and molecular docking. We identified a series of N-phenyl 4-hydroxy-2-quinolone-3- carboxamides as selective inhibitors of mutant H1047R versus wild-type PI3Kα and we also showed that the cell growth inhibition by these compounds likely occurs by inhibiting the formation of pAKT and induction of apoptosis.

KW - AKT phosphorylation

KW - Apoptosis

KW - Colon cancer

KW - PI3K

KW - Selectivity

UR - http://www.scopus.com/inward/record.url?scp=84870053134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870053134&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2012.09.059

DO - 10.1016/j.bmc.2012.09.059

M3 - Article

C2 - 23121722

AN - SCOPUS:84870053134

VL - 20

SP - 7175

EP - 7183

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 24

ER -